Molecular medicine / nucleic acid therapeutics · BEGINNER LESSON
Antisense oligonucleotide
An antisense oligonucleotide is a short, synthetic, single-stranded nucleic acid that binds a chosen RNA sequence by complementary base pairing. It is designed to change gene expression by promoting RNA cleavage or by blocking RNA processing or translation. [0,1,2]
What it is and what is measured
An antisense oligonucleotide, often shortened to ASO, is a small lab-made strand of nucleic acid, usually about 15–30 building blocks called nucleotides long. It is made to bind one chosen RNA sequence through Watson-Crick base pairing, the same kind of matching that pairs bases in nucleic acids. In research and drug development, the main things measured are whether the ASO binds the intended RNA, whether that RNA is cut down or its processing is changed, and whether the amount of protein made from that RNA goes up, down, or is restored. [0,1,2]
[1] Expanding the toolbox: Emerging antisense oligonucleotide ... [2] REVIEW ARTICLE [3] Antisense Oligonucleotide: Basic Concepts and Therapeutic ... - PMC
How ASOs work
ASOs work in two broad ways. Some are designed to recruit RNase H1, an enzyme that recognizes a DNA-RNA duplex and cuts the RNA strand, which lowers the RNA signal and usually reduces protein production. These are often called gapmers and contain a DNA-like core with modified outer regions that help stability and binding. Other ASOs do not cut RNA; instead, they sterically block a process by sitting on an RNA region and preventing splicing, polyadenylation, translation initiation, translation termination, or microRNA activity. Splicing is the step where a pre-mRNA is edited before becoming mature RNA. [0,1,2]
[1] Expanding the toolbox: Emerging antisense oligonucleotide ... [2] REVIEW ARTICLE [3] Antisense Oligonucleotide: Basic Concepts and Therapeutic ... - PMC
Why sequence matching matters
ASOs are sequence-specific, meaning they are designed for a particular RNA sequence or even a particular genetic variant. This gives them high targeting precision, but it also makes design important: the chosen RNA site must be accessible, and the ASO must avoid partial matching to unrelated RNAs. Small changes in gap length, gap position, and chemical modification can shift an ASO toward cleavage or toward steric blocking. [0,1,2]
[1] Expanding the toolbox: Emerging antisense oligonucleotide ... [2] REVIEW ARTICLE [3] Antisense Oligonucleotide: Basic Concepts and Therapeutic ... - PMC
Limitations and challenges
ASOs are powerful, but they are not universally suitable. Delivery to the correct tissue can be difficult, and some diseases or variants do not respond well to this strategy. Off-target effects are a major limitation: the ASO may bind the wrong RNA by sequence similarity, or its chemistry may cause unwanted interactions. The field also notes that the needed level of RNA or protein change for disease rescue is not always known. [0,1,2]
[1] Expanding the toolbox: Emerging antisense oligonucleotide ... [2] REVIEW ARTICLE [3] Antisense Oligonucleotide: Basic Concepts and Therapeutic ... - PMC
SEE THE IDEA
How an antisense oligonucleotide changes RNA behavior
A short synthetic strand is made to match one RNA sequence.
The ASO pairs with the target RNA by complementary bases.
It either recruits RNase H1 to cut RNA or blocks RNA processing/translation.
Target protein output is reduced, modified, or restored.
Design leads to RNA binding, and binding leads to either cleavage or steric blocking.
A sequence-matched ASO can change gene expression by destroying the RNA or by physically blocking RNA use. [0,1,2]
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.